Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.36 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.36 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 4/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.34 |
| ▸ | RAB9A | P51151 | 4/20 | 0.34 |
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29351145 | 1.00 | LMNA (0.38) | LMNAEHMT2EHMT1APOBEC3GHPGD | |
| SCHEMBL8610607 | 1.00 | LMNA (0.38) | LMNAEHMT2EHMT1APOBEC3GHPGD | |
| SCHEMBL109627 | 0.89 | LMNA (0.37) | LMNAEHMT2EHMT1APOBEC3GHPGD | |
| SCHEMBL20384698 | 0.89 | LMNA (0.37) | LMNAEHMT2EHMT1APOBEC3GHPGD | |
| SCHEMBL29398201 | 0.89 | LMNA (0.37) | LMNAEHMT2EHMT1APOBEC3GHPGD | |
| SCHEMBL23086185 | 0.88 | SMN1; SMN2 (0.41) | LMNAHPGDMEN1KMT2ATSHR | |
| Hydrochloric Acid SCHEMBL30767122 | 0.88 | LMNA (0.36) | LMNAEHMT2EHMT1APOBEC3GHPGD | |
| SCHEMBL11367709 | 0.87 | LMNA (0.39) | LMNAEHMT2EHMT1APOBEC3GHPGD | |
| SCHEMBL22415048 | 0.85 | ALDH1A1 (0.35) | LMNAEHMT2EHMT1APOBEC3GHPGD | |
| SCHEMBL10340552 | 0.85 | LMNA (0.34) | LMNAEHMT2EHMT1APOBEC3GHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2275 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2804631-B1 | SURROBODY CONJUGATES | I2 PHARMACEUTICALS INC (US) | 2021-03-17 | — | — | EP | claimed |
| EP-2914630-B1 | NOVEL ANTIGEN BINDING PROTEINS AND THEIR USE AS ADDRESSING PRODUCT FOR THE TREATMENT OF CANCER | PF MEDICAMENT (FR) | 2021-03-03 | — | — | EP | claimed |
| EP-2804631-A1 | SURROBODY COJUGATES | Sea Lane Biotechnologies,llc. (US) | 2014-11-26 | — | — | EP | claimed |
| WO-2013109994-A1 | SURROBODY COJUGATES | SEA LANE BIOTECHNOLOGIES, LLC (US) | 2013-07-25 | — | — | WO | claimed |
| EP-2032172-B1 | LEPTOMYCIN DERIVATIVES | SANOFI SA (FR) | 2012-06-06 | — | — | EP | claimed |
| EP-2386559-A1 | Cytotoxiv agents comprising new tomaymycin derivatives and their therapeutic use | SANOFI (FR) | 2011-11-16 | — | — | EP | claimed |
| US-20110254808-A1 | REFLECTIVE TOUCH DISPLAY PANEL AND MANUFACTURING METHOD THEREOF | AU OPTRONICS CORPORATION (TW) | 2011-10-20 | — | — | US | claimed |
| EP-1813614-B1 | Cytotoxic agents comprising new tomaymycin derivatives | SANOFI SA (FR) | 2011-10-05 | — | — | EP | claimed |
| US-7514078-B2 | Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies | CORNELL RESEARCH FOUNDATION, INC. (US) | 2009-04-07 | — | — | US | claimed |
| US-20260144888-A1 | USE OF A LIQUID AQUEOUS COMPOSITION FOR SOLUBILIZATION AND STABILIZATION OF AN ANTIBODY-DRUG CONJUGATE | PIERRE FABRE MEDICAMENT (FR) | 2026-05-28 | — | — | US | disclosed |
| EP-4748856-A2 | COMPOSITIONS AND METHODS FOR TREATING CANCER WITH SELF-DRIVING CHIMERIC ANTIGEN RECEPTORS | Lentigen Technology, Inc. (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-4748862-A2 | HETERODIMERIC PROTEINS | Xencor, Inc. (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-3620473-B1 | NOVEL HETERODIMERIC PROTEINS | XENCOR INC (US) | 2026-05-27 | — | — | EP | disclosed |
| US-20260139073-A1 | Antigen Binding Proteins | GLAXO GROUP LIMITED (GB) | 2026-05-21 | — | — | US | disclosed |
| US-5165923-A | Anticarcinogenic agents by elimination of cells using a toxin conjugate | IMPERIAL CANCER RESEARCH TECHNOLOGY (GB) | 1992-11-24 | — | — | US | disclosed |
| EP-0502101-A1 | COMPOSITIONS FOR THE TREATMENT OF HODGKIN'S DISEASE | IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 1992-09-09 | — | — | EP | disclosed |
| WO-1991007941-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF HODGKIN'S DISEASE | IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 1991-06-13 | — | — | WO | disclosed |
| WO-1991007437-A2 | IMPROVED CD-30 ANTIBODIES AND FRAGMENTS THEREOF | PARKER, DAVID, L. (US) | 1991-05-30 | — | — | WO | disclosed |
| EP-0428534-A1 | COUPLING AGENTS AND STERICALLY HINDERED DISULFIDE LINKED CONJUGATES PREPARED THEREFROM. | CETUS CORP (US) | 1991-05-29 | — | — | EP | disclosed |
| WO-1989012624-A2 | COUPLING AGENTS AND STERICALLY HINDERED DISULFIDE LINKED CONJUGATES PREPARED THEREFROM | CETUS CORPORATION (US) | 1989-12-28 | — | — | WO | disclosed |